Intercept failed NASH candidate precipitated Alfasigma acquisition Markets September 30, 2023 [ad_1] Mohammed Haneefa Nizamudeen After the failure of Intercept Prescribed drugs’ (ICPT) Ocaliva (obeticolic acid) for nonalcoholic steatohepatitis (NASH) in…
